Чтение онлайн

{24} Aprifel, R^ole b'en'efique des polyph'enols et du resv'eratrol du vin, 2001. Disponible sur:php?m=3&rub=54&a =769 (consult'e le 17 mars 2010).

{25} Adrian et al., Am. J. Enol. Viti c., 2000, 51, p. 37–41.

{26} Renaud S., Lorgeril M. de, «Wine, alcohol, platelets, and the French paradox for coronary heart disease», Lancet, 1992, 339 (8808), p. 1523–1526.

{27} Brisdelli F., D’Andrea G., Bozzi A., «Resveratrol: A natural polyphenol with multiple chemopreventive properties», Curr. Drug Metab., 2009, 10 (6), p. 530–546.

{28} Athar M., Back J. H., Kopelovich L., Bickers D. R., Kim A. L., «Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms», Arch. Biochem. Biophys., 2009, 486 (2), p. 95—102.

{29} Yusuf N., Nasti T. H., Meleth S., «Elmets CA. Resveratrol enhances cellmediated immune response to DMBA through TLR4 and prevents DMBA induced cutaneous carcinogenesis», Mol. Carcinog., 2009, 48 (8), p. 713–723.

{30} Seeni A., Takahashi S., Takeshita K., Tang M., Sugiura S., Sato S. Y., Shirai T., «Suppression of prostate cancer growth by resveratrol in the transgenic rat for adenocarcinoma of prostate (TRAP) model», Asian Pac. J. Cancer Prev., 2008, 9 (1), p. 7—14.

{31} Sengottuvelan M., Deeptha K., Nalini N., «Influence of dietary resveratrol on early and late molecular markers of 1,2-dimethylhydrazineinduced colon carcinogenesis», Nutrition, 2009, 25 (11–12), p. 1169–1176.

{32} Ding X. Z., Adrian T. E., «Resveratrol inhibits proliferation and induces apoptosis in human pancreatic cancer cells», Pancreas, 2002, 25 (4), p. 71–76.

{33} Woodall C. E., Li Y., Liu Q. H., Wo J., Martin R. C., «Chemoprevention of metaplasia initiation and carcinogenic progression to esophageal adenocarcinoma by resveratrol supplementation», Anticancer Drugs, 2009, 20 (6), p. 437–443.

{34} AFSSA, «Table CIQUAL 2008», op. cit.

{35} Direction g'en'erale de la Sant'e, Cancer de la peau. M'elanome, 2003. Disponible sur:peau.pdf (consult'e le 18 mars 2010).

{36} AFSSET, FAQ Rayonnement ultraviolet. Disponible sur: http:// www.afsset.fr/index.php?pageid=634 & parentid=265&ongletlstid=427 (consult'e le 17 mars 2010).

{37} Sayre R. M., Dowdy J. C., «The increase in melanoma: are dietary furocoumarins responsable?», Med Hypotheses, 2008, 70 (4), p. 855–859.

{38} Feskanich D., Willett W. C., Hunter D. J., Colditz G. A., «Dietary intakes of vitamins A, C, and E and risk of melanoma in two cohorts of women», Br. J. Cancer, 2003, 88 (9), p. 1381–1387.

{39} Malik A., Afaq F., Sarfaraz S., Adhami V. M., Syed D. N., Mukhtar H., «Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer», Proc. Natl. Acad. Sci., 2005, 102 (41), p. 14813—14818.

{40} Pantuck A. J., Leppert J. T., Zomorodian N., Aronson W., Hong J., Barnard R. J., Seeram N., Liker H., Wang H., Elashoff R., Heber D., Aviram M., Ignarro L., Belldegrun A., «Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer», Clin. Cancer Res., 2006, 12 (13), p. 4018–4026.

{41} Zhang Y., Seeram N. P., Heber D., Chen S., Adams L. S., «Pomegranate ellagitannin-derived compounds exhibit antiproliferative and antiaromatase activity in breast cancer cells in vitro», Cancer Prev. Res. (Phila Pa), 2010, 3 (1), p. 108–113.

{42} Khan G. N., Gorin M. A., Rosenthal D., Pan Q., Bao L. W., Wu Z. F., Newman R. A., Pawlus A. D., Yang P., Lansky E. P., Merajver S. D., «Pomegranate fruit extract impairs invasion and motility in human breast cancer», Integr. Cancer Ther., 2009, 8 (3), p. 242–253.

{43} Seeram N. P. et al., «In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice», J. Nutr. Biochem., 2005, 16 (6), p. 360–367.

{44} Gil M. I., Tom^as-Barber^an F. A., Hess-Pierce B., Holcroft D. M., Kader A. A., «Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing», J. Agric. Food Chem., 2000, 48 (10), p. 4581–4589.

{45} Khan N., Afaq F., Kweon M. H., Kim K., Mukhtar H., «Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice», Cancer Res, 2007, 67 (7), p. 3475–3482.

{46} Gil M. I., Tom^as-Barber^an F. A., Hess-Pierce B., Holcroft D. M., Kader A. A., «Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing», op. cit.

{47} Khan N., Afaq F., Kweon M. H., Kim K., Mukhtar H. «Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice», Cancer Res, 2007, 67 (7), p. 3475–3482.

{48} Pantuck A. J., Leppert J. T., Zomorodian N., Aronson W., Hong J., Barnard R. J., Seeram N., Liker H., Wang H., Elashoff R., Heber D., Aviram M., Ignarro L., Belldegrun A., «Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer», Clin. Cancer Res., 2006, 2 (13), p. 4018–4026.

{49} Gil M. I., Tom^as-Barber^an F. A., Hess-Pierce B., Holcroft D. M., Kader A. A., «Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing», op. cit.

{50} MacMahon B., Yen S., Trichopoulos D., Warren K., Nardi G. «Coffee and cancer of the pancreas», N. Engl. J. Med., 1981, 304 (11), p. 630–633.

{51} Nkondjock A., «Coffee consumption and the risk of cancer: An overview», Cancer Lett., 2008, 277 (2), p. 121–125.

{52} World Cancer Research Fund, Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective, op. cit.

{53} Pelucchi C., Tavani A., La Vecchia C., «Coffee and alcohol consumption and bladder cancer», Scand. J. Urol. Nephrol., 2008, 218, suppl., p. 37–44.

{54} Baker J. A., Beehler G. P., Sawant A. C., Jayaprakash V., Mc-Cann S. E., Moysich K. B., «Consumption of coffee, but not black tea, is associated with decreased risk of premenopausal breast cancer», J. Nutr., 2006, 136 (1), p. 166–171.

{55} Nkondjock A., Ghadirian P., Kotsopoulos J., Lubinski J., Lynch H., Kim Sing C., Horsman D., Rosen B., Isaacs C., Weber B., Foulkes W., Ainsworth P., Tung N., Eisen A., Friedman E., Eng C., Sun P., Narod S. A., «Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers», Int. J. Cancer, 2006, 118 (1), p. 103–107.